Disseminated Nontuberculous Mycobacterial Infection in a Patient with Anti-IFN-γ Autoantibodies by Tanimizu, Masakuni et al.
T he main infection site of nontuberculous myco-bacterial infection (NTM) is the lungs,  and dis-
seminated NTM infection is rare in general.  A dissem-
inated NTM infection is an opportunistic infection 
accompanied by congenital or acquired immunodefi-
ciency disease such as AIDS,  hematological malig-
nancy,  or immunosuppressive therapy [1-3].  The pres-
ence of serum anti-interferon-gamma (IFN-γ) 
autoantibodies was recently reported to be involved in 
the onset of disseminated NTM infection in immuno-
competent patients in Asia [3].  Here we report a case of 
disseminated NTM infection in a patient with anti-
IFN-γ autoantibodies.
Case Report
A 72-year-old Japanese female was admitted to our 
hospital due to sustained high fever and overall body 
exhaustion.  An infectious liver cyst (S2 subarea) and 
right lung pneumonia were suspected causes.  However,  
hepatic cystectomy and the administration of various 
antibiotics did not resolve the symptoms.  On the con-
trary,  the pneumonia worsened (Fig. 1A), and ascitic 
fluid retention (Fig. 1B) and left back pain appeared.
A blood biochemical analysis revealed anemia,  neu-
trophil dominant leukocytosis,  and a high C-reactive 
protein (CRP) value.  Several bacterial blood and spu-
tum culture tests were negative.  Echocardiography did 
not show vegetations.  Acid-fast bacteria were not indi-
cated by sputum smear microscopic observation.  
Although an ascites puncture test showed an increase in 
lymphocyte-dominant cells,  a bacterial culture exam-
ination and mycobacterium tuberculosis polymerase 
chain reaction (TB-PCR) analysis of ascites were nega-
tive.  Increased levels of adenosine deaminase (ADA) in 
ascites were not observed (Table 1).
We were unable to determine the causes of these 
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symptoms.  One month after the patient’s admission,  a 
high titer of serum anti-mycobacterium avium complex 
(MAC) antibodies was indicated.  Mycobacterium 
avium (M. avium) was identified by cultures of both 
ascites and sputum at 2 weeks post-cultivation (Fig. 1C).  
Subsequently,  the patient’s left lower back pain was 
diagnosed as purulent spondylitis with bone destruc-
tion of the fifth lumbar vertebra (Fig. 2A).  M. avium 
was identified by smear microscopic observation and a 
MAC-PCR analysis of a specimen obtained by abscess 
puncture (Fig. 2B).
A computed tomography (CT) scan of the abdomen 
and esophagogastroduodenoscopy (EGD) indicated that 
a peri-gastric lymph node abscess had ruptured inside 
the gastric lumen (Fig. 3A , B).  M. avium was also iden-
tified in the previous examination from the discharged 
pus (Fig. 3C).  Although both blood and bone marrow 
culture of mycobacteria were negative,  based on these 
results,  disseminated NTM infection was finally diag-
nosed.
The patient did not have any inherited immune sys-
tem disorders.  Although the patient seemed to be 
immunocompetent,  we considered the possibility of 
adult-onset immunodeficiency.  Tests for viral infections 
that cause impaired immune function,  such as human 
immune deficiency virus (HIV),  human T-cell leuke-
mia virus (HTLV-1) and Epstein Barr virus (EBV),  
were negative.  No steroids or anticancer/anti-cytokine 
drugs were used.  Diabetes and hematological malig-
nancies were not indicated.  According to the immuno-
logical examination,  serum immunoglobulin was 
within normal levels,  and no decrease in lymphocyte or 
actual CD4 count was observed.  The result of a 
3rd-generation IFN-γ release assay (IGRA) was indeter-
minate because the positive control was a very low titer 
at 0.05 IU/ml.  Consequently,  we suspected some 
immune disorders related to IFN-γ as the underlying 
cause.
A high titer of IFN-γ autoantibodies was detected in 
the patient’s serum at 51,442 AU (IgG type using an 
in-house enzyme-linked immunosorbent assay). These 
were recognized as neutralizing antibodies based on our 
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Fig. 1　 A,  Computed tomography of the chest showed an invasive shadow in the upper right lobe (➡); B,  Computed tomography of the 
abdomen showed ascites after hepatic cyst surgery (▷); C,  Cultured acid-fast bacteria at 2 weeks (⇨).  
observation that the phosphorylation of signal trans-
ducer and activator of transcription 1 (STAT1), which is 
generated as intracellular signaling upon stimulation of 
a human peripheral blood lymphocytic cell line with 
IFN-γ,  was suppressed by the patient’s serum.
Multi-drug combination chemotherapy was initiated 
with rifabutin (RBT) 300 mg once daily orally,  etham-
butol hydrochloride (EB) 750 mg once daily orally,  
clarithromycin (CAM) 800 mg twice daily orally and 
streptomycin sulfate (SM) 0.5 g 3 times per week intra-
muscular injection.  After the administration,  gradual 
improvement in constitutional symptoms and left back 
pain,  a decrease in ascites,  and shrinkage of the 
shadow on the right lung were observed.  As of this 
writing,  recurrence was not reported and this multi-
drug combination chemotherapy has been continued 
for 14 months with careful observation.
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Table 1　 Laboratory data
Blood biochemical test Viral infection
WBC 17,800/µl HCV-RNA (-)
Ba 0.1% HBs-antigen (-)
Eo 3.6% HIV (-)
Nt 84.8% HTLV-1 (-)
Ly 7.8% IgG-VCA ×80
Mo 3.7% EBNA ×40
Hb 9.1 g/dl C7-HRP (-)
PLT 48.0×104/µl β-D-glucan ＜5.0 pg/ml
IGRA Undecidable
AST 15 IU/L (®QuantiFERON TB-3G)
ALT 11 IU/L Anti-MAC antibody 10.0 U/ml
LDH 207 IU/L
ALP 486 IU/L Immunological test
γ-GTP 155 IU/L IgG 1,250 mg/dl
BUN 10.8 mg/dl IgA 320 mg/dl
Cr 0.61 mg/dl IgM 95 mg/dl
FPG 104 mg/dl IgE 92.6 IU/ml
HbA1c (NGSP) 5.8% sFLC ratio 0.664
CRP 16.4 mg/dl CD4 45.1%
ESR 111 mm/hour CD8 22.5%
Actual CD4 count 478/µl
Ascites IFN-γ autoantibody 51,442 AU
Rivalta reaction (+)
Cell count 2,099/m3 HLA typing
(Nt. : Ly. ratio 3 : 7) HLA-DRB1 allele
allele 1　04 : 05
ADA 10.9 U/L allele 2　08 : 03
Bacterial culture (-) HLA-DQB1 allele
Acid-fast smear (-) allele 1　04 : 01
TB-PCR (-) allele 2　06 : 01
Cytology (-)
550 Tanimizu et al. Acta Med.  Okayama　Vol.  71,  No.  6
A B
Fig. 2　 A,  X-ray of the spine showed bone destruction in the left ﬁfth vertebral body (⇨); B,  Computed tomography of the abdomen 
showed abscess in the left ﬁfth vertebral body (⃝).  
C
BA
Fig. 3　 A,  Computed tomography of the abdomen showed peri-gastric lymphadenopathy with low CT value (⇨); B,  Lymph node 
abscess ruptured inside the stomach (➡); C,  Pus in the stomach collected using forceps.
Discussion
NTM is an environmental bacterium,  and dissemi-
nated NTM infection is generally rare.  Disseminated 
NTM infection often develops as an opportunistic 
infection due to AIDS,  immunosuppressive therapy 
such as steroids,  hematological malignancy or congen-
ital immune disorder [1-3].  An increasing number of 
disseminated NTM infections have recently been 
reported in Asia,  especially strains that produce neu-
tralizing autoantibodies to IFN-γ [3].  Some similar 
cases have also been reported in Japan [4 , 5].  In our 
patient’s case,  adult-onset immunodeficiency was not 
indicated from her medical history and various immu-
nological tests.  Since the IGRA result was undecidable,  
we suspected some underlying disorders in the interleu-
kin (IL)-12/IFN-γ pathway,  which is an important 
defense mechanism against acid-fast bacterial infections 
[2 , 6].  A high titer of autoantibodies to IFN-γ was 
detected in our patient’s blood,  and was also shown 
have a neutralizing effect.  As a result,  this is considered 
to be involved in the onset of the patient’s disseminated 
NTM infection.
Florent et al.  summarized the characteristics of 
64 patients with anti IFN-γ autoantibody-related NTM 
infection [7].  In their report,  the median age was 
48 years old,  and Asian-born patients and female gen-
der predominated.  M.  avium is the most common 
species that causes disseminated NTM infection,  but 
other species of mycobacteria such as M.  abscessus,  a 
rapid-growing NTM,  have been reported as causes of 
this condition.  Also,  according to the Florent et al.  
report,  infectious sites of high frequency were lymph 
node and lung,  bone and/or joint.  Other opportunistic 
infections,  especially reactivation of herpes and salmo-
nella infections,  have often been observed in dissemi-
nated NTM infections in patients with anti-IFN-γ auto-
antibodies [7 , 8].
Our patient was a Japanese woman,  older than the 
median age in the Florent et al.  report.  The etiological 
agent was M. avium,  one of the most frequent species of 
mycobacteria.  In our patient’s case,  the disseminated 
NTM infection was diagnosed by isolating M. avium 
from sputum,  ascites,  an abscess in a lumbar vertebra 
and pus in the gastric lumen from a peri-gastric lymph 
node.  The isolation of M.  avium from the peritoneum 
is relatively rare.  The reported opportunistic infections 
were not observed in our patient (Table 2).
The question of why many more cases of dissemi-
nated NTM with anti-IFN-γ autoantibodies are 
reported in Asians compared to Caucasians has not 
been answered.  Chin et al.  reported that HLA-DRB1＊
16: 02 and HLA-DQB1＊ 05: 02 are associated with 
disseminated NTM infection with anti-IFN-γ autoanti-
bodies expression in Asians [8].  According to their 
report,  aspects of a patient’s genetic background such as 
race may be a factor in the onset of illness.
In our patient,  an HLA test was also performed with 
informed consent,  but recognized types of HLA were 
not detected (Table 2). Treatment for disseminated 
NTM infection with anti-IFN-γ autoantibodies has not 
been standardized.  Conventionally,  prolonged multi-
drug regimens are implemented.  Florent et al.  reported 
that among patients with a long-term administration of 
a multi-drug regimen,  approx.  37.5% of the cases 
resulted in recovery,  10.7% were fatal,  and over 51.8% 
were resistant or recurrent [7].  Consequently,  in addi-
tion to anti-infection treatment,  other strategies 
including IFN-γ replacement therapy [9 , 10] and intra-
venous immunoglobulin (IVIG) [11],  and the com-
bined use of plasmapheresis and cyclophosphamide 
[12] have been implemented.  However,  the efficacy has 
been inconclusive.
In recent years,  an improvement in refractory 
patients with high titers of anti-IFN-γ autoantibodies by 
rituximab administration has been reported; not only 
did clinical symptoms improve but the serum anti-
IFN-γ autoantibodies titer also decreased along with its 
neutralizing activity [13].  This treatment is considered 
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Table 2　 Summary of our case
SEX Women
Age 72 years old
Infectious site Sputum
Ascites,
Abscess in the lumbar vertebrae 
Peri-gastric lymph node
Etiological agents Mycobacterium avium
Other opportunistic infections
Herpesviridae reactivation Not observed
Salmonella spp. Not observed
Two HLA alleles that is presumed to
be related to the onset
HLA-DRB1＊16 : 02 Not Detected
HLA-DQB1＊05 : 02 Not Detected
to be effective,  and further findings to support this are 
expected.
In our patient’s case,  a favorable clinical course 
could be obtained by anti-infection treatment.  
However,  serum anti-IFN-γ autoantibodies titers have 
been reported to remain high for a long time even when 
infection control was obtained [13].  A careful follow-up 
of the transitional course is needed.
In conclusion,  we treated a patient with dissemi-
nated NTM (M. avium) infection with anti-IFN-γ auto-
antibodies.  When the presence of a disseminated NTM 
infection is detected in an immunocompetent patient,  
the presence of serum anti-IFN-γ autoantibodies should 
be considered.
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